UK trial regulation may support haemophilia treatment access

The new MHRA scheme helps to reduce the time it takes for the lowest-risk clinical trials to commence, while maintaining patient safety.

Related Keywords

United Kingdom ,Andrea Manfrin ,Regulatory Agency ,Research Application System ,Notification Scheme ,Clinical Trial Authorisations ,Clinical Investigations ,Integrated Research Application System ,